|
Index of reports
> Cases resulting in a serious event (4)
Below is the selection of adverse event reports related to Amerge (Naratriptan) that includes cases resulting in a serious event.
Adverse event in female receiving Amerge (Naratriptan)
Reported by a consumer/non-health professional from United States on 2007-07-12
Patient: female
Adverse reactions / side effects: Arteriospasm Coronary, Cardiomyopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge
Administration route: Oral
Indication: Migraine
Imitrex
Administration route: Oral
Indication: Migraine
Axert
Indication: Migraine
Frova
Relpax
Adverse event in female receiving Amerge (Naratriptan)
Reported by a consumer/non-health professional from United States on 2007-06-28
Patient: female
Adverse reactions / side effects: Arteriospasm Coronary, Cardiomyopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge
Administration route: Oral
Indication: Migraine
Imitrex
Administration route: Oral
Indication: Migraine
Frova
Relpax
Adverse event in 49 year old female receiving Amerge (Naratriptan)
Reported by a individual with unspecified qualification from Germany on 2007-05-07
Patient: 49 year old female
Adverse reactions / side effects: Hepatitis Viral, Autoimmune Hepatitis, Chronic Hepatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge
Dosage: twice per day
Indication: Migraine
Start date: 2006-12-01
End date: 2006-12-01
Rizatriptan Benzoate
Ibuprofen
Dosage: as required
Indication: Migraine
Adverse event in female receiving Amerge (Naratriptan)
Reported by a pharmacist from Canada on 2007-04-12
Patient: female
Adverse reactions / side effects: Cardiac Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Amerge (Naratriptan)
|
